The preparation for consideration is the highly dispersed camphor emulsion ECADO manufactured using a special know-how and based on the carrier developed by Dr. Chernobayev to ensure its rapid absorption. The pharmacological mechanism of action of the drug is described in the "Theory" section. However it is still misunderstood by many physicians, not mentioning patients.

Prostate adenoma is now believed to develop, sooner or later, in every man old enough. Notable changes in the prostate appear even at younger ages, from about 30 to 40 years. Therefore, many men who are older than 35 suffer from chronic prostatitis, and after a few years adenomatous nodes develop. In 40-80% of patients this is associated with impaired sexual function. Age-associated changes in the prostate are likely to be naturally programmed. If so, how can they be prevented? This is what the easy-to-use drug ECADO is designed for. It has been patented and has no analogues in the world. When used in therapy for prostate adenoma it allows not only to eliminate the clinical manifestations of the condition but, also, to decrease the size of the enlarged prostate by 40%, on average, in a very short time. How it comes? The daily secretion by the prostate must be minimum 2 ml. This amount is either discharged with the sperma or, where no regular sexual intercourses occur, is excreted with urine imperceptibly. In older ages and in the cases of inflammation the latter does not occur. The secretory units of the prostate, its acini, which produce their secretion perpetually, become overfilled with their thick and viscous secretion and become vulnerable to infection. Just imagine a jar of milk on a window-still. In 24 h, there will be milk whey above and clabber below. Every tissue of human body, including blood, urine and even bone, is a biocolloid vulnerable to natural aging (colloidoclasia).

ECADO preparation is quickly absorbed. Camphor, being one of its components, is released in an unchanged way in prostate and ensures dilution and removal of its secretion.
Camphor provides normal level of the hormones which are constantly present in prostate and normalization of their ratio. Scientific research already exists in this sphere. This is important to understand the pathogenesis of progression of adenoma and prostate cancer.

The use of ECADO provides for rapid restoration of the resistance of prostate secretion to its aging, for recovery of its fluidity and bactericidal activity and, by virtue of improved fluidity, for enhanced ability to pass through narrow ducts in the prostate gland.

A short-term treatment of the prostate with the drug easily eliminates the pathogenic microflora in the gland. The microflora affected by the treatment includes Gram-negative and Gram-positive bacteria, viruses, trichomonas species, fungi, chlamydia, mycoplasmas, ureaplasma, etc.

The acini of the prostate become enabled to easily empty themselves, and the manifestations of their malfunctioning disappear together with the accompanying inflammation.

The aforesaid relates to prostatitis and its result, prostate adenoma. The following discussion relates to the ability of ECADO to restore sexual potency. Camphora is generally known to stimulate breathing and heartbeat and to dilate blood vessels in the heart and brain. The control centers of these functions are located in the parasympathetic compartment of the spinal cord (the medulla). The other part of this parasympathetic nervous system is localized in the sacral compartment of the nervous system where the center that controls erection resides. ECADO stimulates this center, which leads to dilation of the cavernous bodies of the penis.

The use of ECADO to treat erectile dysfunctions and impaired ejaculation in patients aged above 75 affords excellent results. In recent years this approach has been used to treat patient aged above 90, and good results were obtained.

ECADO is the first drug worldwide to be useful not only for treatment of prostatitis, male infertility, benign prostate hyperplasia, and impotence, but also for prevention of these conditions. However, if the age-associated changes in the prostate are programmed and, thus, are inevitable, how could they be avoided or delayed? How surgery on the prostate could be avoided? When the relevant prophylactic treatment should be started?

Dr. Chernobayev suggests a program for prevention of these conditions using monotherapy with ECADO.

This is as simple as the following. You brush your teeth in the morning to prevent caries and use ECADO by night, which is easy to get used to. Much depends upon when, at which stage of the continuing and distressing process of aging, you start seeking medical attention. It is never late to start treatment. However, longer treatment is needed when prostate adenoma has already developed. Then supportive courses of treatment with ECADO are sufficient.

THE TREATMENT REGIMEN FOR PREVENTION OF PROSTATITIS, BENIGN HYPERPLASIA OF THE PROSTATE, IMPOTENCE, AND PROSTATE CANCER

1. The onset of prophylactic treatment.
   No symptoms of the conditions are evident.
   The age is 35-45 years.
   Treatment regimen: 20-40 days of every other day treatment annually.
   Recommendations:
   - urine tests
   - blood tests
   - ultrasonic examination
   - prostate palpation
   - spermogram (to be compares with earlier results).
2. Symptoms include the sensations of heaviness and pain in the perineum, local sweating in the scrotum? reduced urine pressure, nocturnal urges for urination about 1 time per night, premature ejaculation, and incomplete or unstable erection.
   The age is usually 35-48 years.
   Treatment regimen: two courses lasting for 30-50 days annually.
   Recommendations:
   - urine tests
   - blood tests
   - ultrasonic examination
   - prostate palpation
   - PSA
3. Expressed symptoms including frequent urination reaching two times overnight and causing "WC-bounding" in the daytime; flaccid urine jet and the need to squeeze urine out in the end of urination; the sensations of heaviness and pain in the perineum and in the sacral area in the morning and of pain above the pubic area; unstable and incomplete erection and premature ejaculation.
   The age is 46-48 years or older.
   Treatment regimen: daily procedures for 40-60 days 2-3 times annually.
   Recommendations:
   - urine tests
   - blood tests
   - blood sugar
   - blood bilirubin
   - blood creatinine
   - ultrasonic examination
   - PSA
   - prostate palpation.
   It is advised that a patient achieves some stable level of symptoms in the course of using ECADO and determines his attitude towards this level and related quality of life. The treatment with ECADO should be repeated when patient's condition worsens. In this case, the drug should be used more frequently.

ECADO is sent to foreign customers by mail after prepayment is made by remittance to the banking account specified below. The price of a kit for 20 days of use is US$ 195. The customer shall notify about the remittance of this amount and also inform of his/her personal data and postal address.

Beneficiary Institution
SABRRU2P - Saving Bank of the Russian Federation (Severo-Zapadny Office)
St. Petersburg Tosno Branch.
Beneficiary Customer
42301840355385000265 Chernobayev Nikolay
Remittance information (This field consisting of 4 lines, 35 symbols each, may be filled with information related to the remittance).

Indications: Stage 1 and 2 prostate adenoma, chronic prostatitis, male infertility, sexual weakness, prophylaxis of prostate cancer.

Contraindications: epilepsy, glaucoma, individual intolerance.

Side effects: in some cases, local reactions manifested as mild itch are possible.

Dosage and usage: The typical dose is 4-5 ml of emulsion. The preparation is administered rectally once a day by night. To this, pull the plunger out of the syringe and fill it with emulsion up to the mark 5. Then put the plunger back, lubricate the tip and insert it into the anus till fixed stop. Push out the contents. Wash the syringe with warm water and soap. Treatment regimen: daily intrarectal administrations of 5 ml of the emulsion for 2 months in cases of chronic prostatitis, for 3-4 months in cases of prostate adenoma, 1.5-2 months in cases of sexual failure, and 2-6 months in cases of infertility. No physiotherapy and massage of the prostate and no other drugs are needed.

Note: Do not use the preparation after the expiry date. Store it in a dry cool place protected from light.

Shelf life: two years.

Kit contents: Three 45-ml tubes, microclyster and instruction (check the appearance).

The preparation ECADO is used by prescription of doctor Chernobayev, urologist.

The right to formulate the preparation ECADO belongs to Chernobayev N.Ye. and is protected by the Laws of the Russian Federation as related to author's rights and intellectual property.

Manufactured by MPP "Farmatsiya", Saint-Petersburg, by the author's license.

The preparation ECADO is not subjected to obligatory certification basing on the Regulations of Medicinal Drug Registration in the Russian Federation.

REQUEST FOR TREATMENT

Please indicate the following where possible:
Family name, first name, patronymic.
Age.
Marital status.
Profession.
Home address.
Telephone number.
Data of clinical, laboratory and other examinations.
Prior treatment(s) (surgical or therapeutic).
Prior drugs.
Concomitant diseases.

Addressing the Consulting Center ECADO for Men is available for anyone irrespective of age or place of residence. Here is our contact information.